A rising selection of processed food over natural sustenance is relied upon to build frequency pace of interminable issue and frail resistant system among individuals. This is one of the significant motivations to treat the scatters through plasmapheresis, which will drive the plasma component separator market.
Blood is the mind-boggling blend of white platelets (WBC), red platelets (RBC), Plasma (fluid part), and platelets. Plasma comprises around 55-60% of blood volume. Plasma contains 90% water and 10% solutes, for example, salts, proteins, metabolites, and so on. The plasma is isolated into its subordinates, for example, fibrinogen, globulins, egg whites and different coagulating factors. Plasma separators are utilized to isolate plasma from blood packs and are gathered in exchange sacks. The plasma separators are essentially utilized in indicative labs, restorative specialists to concentrate and separate plasma for research or diagnostic reason.
The global Plasma Component Separators market is segregated on the basis of Disease Indication as Hematology, Nephrology, Oncology, and Others. Based on Technology the global Plasma Component Separators market is segmented in Centrifugation, Filtration, and Membrane Plasma Separation technique. Based on End-User the global Plasma Component Separators market is segmented in Pharmaceutical and Biotechnological Industry, Blood Banks, Research/ Academic Institutes, Hospitals, and Diagnostic laboratory.
The global Plasma Component Separators market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Plasma Component Separators market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Toray Medical, Kawasumi Laboratories, Asahi Kasei Medical, Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, B Braun Melsungen AG, and others are among the major players in the global Plasma Component Separators market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Plasma Component Separators Market has been segmented as below:
Plasma Component Separators Market, By Disease Indication
Plasma Component Separators Market, By Technology
Plasma Component Separators Market, By End-User
Plasma Component Separators Market, By Region
Plasma Component Separators Market, By Company
The report covers:
Report Scope:
The global Plasma Component Separators market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Plasma Component Separators market share. Major industry players with significant revenue share include Toray Medical, Kawasumi Laboratories, Asahi Kasei Medical, Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, B Braun Melsungen AG, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Blood Plasma Fractionation Market
Therapeutic Medical Device Market
Computed Tomography Devices Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Plasma Component Separators Market, By Disease Indication
5.1 Introduction
5.2 Hematology
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Nephrology
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Oncology
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Others
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Plasma Component Separators Market, By Technology
6.1 Introduction
6.2 Centrifugation
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Filtration
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Membrane Plasma Separation technique
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Plasma Component Separators Market, By End-User
7.1 Introduction
7.2 Pharmaceutical and Biotechnological Industry
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Blood Banks
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Research/ Academic Institutes
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Hospitals
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Diagnostic laboratory
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8. Plasma Component Separators Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Plasma Component Separators, By Disease Indication
8.2.2 North America Plasma Component Separators, By Technology
8.2.3 North America Plasma Component Separators, By End-User
8.3 Europe
8.3.1 Europe Plasma Component Separators, By Disease Indication
8.3.2 Europe Plasma Component Separators, By Technology
8.3.3 Europe Plasma Component Separators, By End-User
8.4 Asia-Pacific
8.4.1 Asia-Pacific Plasma Component Separators, By Disease Indication
8.4.2 Asia-Pacific Plasma Component Separators, By Technology
8.4.3 Asia-Pacific Plasma Component Separators, By End-User
8.5 Rest of the World
8.5.1 Rest of the World Plasma Component Separators, By Disease Indication
8.5.2 Rest of the World Plasma Component Separators, By Technology
8.5.3 Rest of the World Plasma Component Separators, By End-User
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Toray Medical
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Kawasumi Laboratories
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Asahi Kasei Medical
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Haemonetics Corporation
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Fresenius Medical Care
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Terumo BCT
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 B Braun Melsungen AG
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
The Plasma Component Separators Market has been segmented as below:
Plasma Component Separators Market, By Disease Indication
Plasma Component Separators Market, By Technology
Plasma Component Separators Market, By End-User
Plasma Component Separators Market, By Region
Plasma Component Separators Market, By Company
